Business Unit Strategy for a Major Pharmaceutical Company
Client Situation.
• US Business Unit with multiple complementary products in a multi-billion franchise
–Multiple Therapeutic Approaches (Multi-class)
–Multiple Brand Competitors (Same Class)
–At least one generic (and several with multiple) in all classes
• NCEs, Formulation and Dosage Changes in client and competitive pipelines
Norbridge Assignment
• Identify and evaluate business unit and product life cycle strategies
• Determine growth acceleration strategies & tactics for in-line portfolio
• Gap analysis to maintain franchise growth and long-term sustainability
• Market & Product Forecasts
• P&L Financial Model
Results
• Multi-product business unit strategy
• Product Life Cycle plans including clinical trials, formulation/dosage modifications, patient and physician targeting, payer/contracting strategy
• Franchise has continued to grow and implement plans
• Client retained Norbridge to provide ongoing monitoring and support to the annual strategic/brand plans and new product assessments